US FDA's Patrick Frey Joins List Of Agency Leadership Departures
Executive Summary
Office of New Drug's chief of staff will become Amgen's director of global regulatory policy and R&D.
You may also be interested in...
Leader Of US FDA's EU Mutual Recognition Effort Departs For Industry
Dara Corrigan will become Fresenius-Kabi’s VP for global affairs and policy.
US FDA Generic Drug Office Director Uhl Announces Retirement
Uhl, who shepherded OGD into the user fee era, will retire in February.
CDER Safety Overhaul Planned As Review Process Modernization Continues
US FDA's Woodcock tells the Pink Sheet that goals include eliminating duplication through creation of one safety review process.